193 related articles for article (PubMed ID: 14574438)
1. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice.
Huotari M; García-Horsman JA; Karayiorgou M; Gogos JA; Männistö PT
Psychopharmacology (Berl); 2004 Feb; 172(1):1-10. PubMed ID: 14574438
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats.
Männistö PT; Tuomainen P; Toivonen M; Törnwall M; Kaakkola S
J Neural Transm Park Dis Dement Sect; 1990; 2(1):31-43. PubMed ID: 2113389
[TBL] [Abstract][Full Text] [Related]
3. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
5. Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
Huotari M; Gainetdinov R; Männistö PT
Pharmacol Toxicol; 1999 Nov; 85(5):233-8. PubMed ID: 10608486
[TBL] [Abstract][Full Text] [Related]
6. Effect of conditioning with d-amphetamine on the extracellular concentration of dopamine and its metabolites in the striatum of behaving rats.
Dietze S; Kuschinsky K
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):22-7. PubMed ID: 7935850
[TBL] [Abstract][Full Text] [Related]
7. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
8. Cyclo (His-Pro), d-amphetamine and striatal dopamine: a microdialysis study.
Levy A; Stillman MJ; Rauch TM
Brain Res Bull; 1991 Jul; 27(1):129-31. PubMed ID: 1933425
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
Brannan T; Martínez-Tica J; Yahr MD
Neurology; 1992 Mar; 42(3 Pt 1):683-5. PubMed ID: 1549240
[TBL] [Abstract][Full Text] [Related]
10. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
Törnwall M; Tuomainen P; Männistö PT
Eur J Pharmacol; 1993 Aug; 239(1-3):39-45. PubMed ID: 8223912
[TBL] [Abstract][Full Text] [Related]
11. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
Kaakkola S; Wurtman RJ
Brain Res; 1992 Aug; 587(2):241-9. PubMed ID: 1381981
[TBL] [Abstract][Full Text] [Related]
12. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
[TBL] [Abstract][Full Text] [Related]
13. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
Sershen H; Harsing LG; Hashim A; Lajtha A
Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
[TBL] [Abstract][Full Text] [Related]
14. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
Tuomainen P; Törnwall M; Männistö PT
Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
[TBL] [Abstract][Full Text] [Related]
15. L-DOPA exacerbates amphetamine-induced dopamine depletion.
Myers CS; Witten M; Yu YL; Wagner GC
Mol Chem Neuropathol; 1998 Feb; 33(2):81-97. PubMed ID: 9565967
[TBL] [Abstract][Full Text] [Related]
16. Effects of CGP 28014 on the in vivo release and metabolism of dopamine in the rat striatum assessed by brain microdialysis.
Steulet AF; Stöcklin K; Wicki P; Waldmeier P
Neurochem Res; 1993 Nov; 18(11):1131-6. PubMed ID: 8255364
[TBL] [Abstract][Full Text] [Related]
17. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
Männistö PT; Tuomainen P; Tuominen RK
Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144
[TBL] [Abstract][Full Text] [Related]
18. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
Männistö PT; Tuomainen P
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
[TBL] [Abstract][Full Text] [Related]
19. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.
Desole MS; Miele M; Enrico P; Fresu L; Esposito G; De Natale G; Miele E
Neurosci Lett; 1992 May; 139(1):29-33. PubMed ID: 1407680
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
